Northwestern University has announced that Amy S. Paller, MD, will step down as chair of the Department of Dermatology at the Feinberg School of Medicine, closing a defining chapter for one of academic dermatology's most prominent departments.

The university confirmed the leadership transition in an announcement titled "Transitions in Dermatology Leadership: Dr. Amy S. Paller to Step Down as Chair." The move marks a shift at the top of a department that Dr. Paller has led while building a national reputation in pediatric dermatology, genodermatoses research and clinical training.

For practicing dermatologists, the news matters beyond institutional politics. Departmental leadership at academic medical centers shapes referral pipelines, fellowship pipelines and the research agenda that eventually reaches community clinics — from biologic therapeutics in children to gene-based approaches for inherited skin disease.

Who is Dr. Paller?

Dr. Paller is one of the most widely recognized figures in American dermatology. Her clinical and scientific career has centered on pediatric dermatology, and she holds a long-standing appointment at Northwestern University Feinberg School of Medicine, where she has served as department chair.

Her name is familiar to clinicians across the specialty through several channels:

• Authorship of standard reference texts in pediatric dermatology used in training programs nationwide
• Sustained research output in genodermatoses, including inherited disorders of cornification and vascular anomalies
• National leadership roles within organized dermatology and its scientific societies
• Mentorship of generations of residents and fellows who now practice across the country

The announcement of her decision to step down as chair signals a planned transition rather than an abrupt departure from the institution, though the announcement did not specify a successor or an exact effective date.

What does the transition change?

A chair vacancy at a top-10 research medical school sets several processes in motion. Northwestern will need to name an interim or permanent leader for the Department of Dermatology, and the search will be watched closely by academic dermatology programs that compete for the same pool of physician-scientist candidates.

For the specialty at large, the transition raises practical questions:

• Continuity of research programs. Labs and multi-investigator grants anchored by a long-tenured chair require transition planning, particularly where early-career investigators depend on departmental infrastructure.
• Fellowship and residency positioning. Applicants weigh departmental leadership stability heavily when ranking programs.
• Referral networks. Community dermatologists who refer complex pediatric and genodermatosis cases to Northwestern will look for signals of continuity in the months ahead.

Northwestern's announcement did not detail the timeline for naming a successor or the mechanics of the search, details that typically follow in institutional communications once a transition plan is finalized.

Why leadership transitions matter in academic dermatology

Chair transitions at major academic departments are infrequent and consequential. The average tenure of a department chair in U.S. academic medicine spans roughly a decade, and departures often coincide with strategic inflection points — new research buildings, changes in affiliated health-system priorities, or generational turnover in faculty.

Dr. Paller's chairmanship at Northwestern has coincided with a period of extraordinary change in the specialty: the expansion of biologic therapy in pediatric inflammatory disease, the emergence of gene therapy for epidermolysis bullosa and related disorders, and growing integration of dermatology into precision-medicine frameworks.

Whoever succeeds her will inherit a department with a strong national profile and the expectations that come with it — maintaining clinical volume, competing for National Institutes of Health funding, and continuing the training pipeline that Northwestern has built under her leadership.

What comes next

The announcement leaves open the questions practitioners and trainees will ask first: when the transition takes effect, whether Dr. Paller continues in an active clinical and research role at Northwestern, and who will lead the department going forward.

Institutional announcements of this kind are typically followed by details on interim leadership and the search process, and Derm Field will track those developments as Northwestern releases them. For now, the specialty marks the close of a long and influential chairmanship — and watches a marquee academic department prepare for its next era.